How many institutions held LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in Q2 2022?

78 institutional investors reported LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share for Q2 2022. Use the holders table for investor-level position and value details.

STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Q: What does CUSIP 34385P108 represent in this 13F holders report?

CUSIP 34385P108 is the security identifier for LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 34385P108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 390,636,209
Total 13F shares: 43,847,181
Share change: -6,138,280
Total reported value: $70,155,656
Put/Call ratio: 137%
Price per share: $1.60
Number of holders: 78
Value change: -$17,366,200
Number of buys: 39
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 34385P108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Indaba Capital Management, L.P.	13F	Company	1.9%	7,446,229	$26,732,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.6%	6,165,716	$22,135,000	—	31 Mar 2022	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.3%	5,025,073	$18,040,000	—	31 Mar 2022	13F
Neuberger Berman Group LLC	13F	Company	1%	3,951,995	$14,219,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1%	3,916,832	$14,061,000	—	31 Mar 2022	13F
NEEDHAM INVESTMENT MANAGEMENT LLC	13F	Company	0.97%	3,778,338	$13,565,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.76%	2,960,031	$10,627,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.59%	2,302,278	$8,265,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.41%	1,599,180	$5,869,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.39%	1,538,106	$5,522,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.34%	1,338,756	$4,806,000	—	31 Mar 2022	13F
PFM Health Sciences, LP	13F	Company	0.25%	980,505	$3,520,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.25%	970,570	$3,485,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.22%	850,000	$3,052,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.21%	830,029	$2,980,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.19%	732,312	$2,628,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	694,491	$2,493,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.18%	687,046	$2,467,000	—	31 Mar 2022	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.1%	400,288	$1,437,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.07%	280,186	$1,006,000	—	31 Mar 2022	13F
Stephen Christopher Linthwaite	3/4/5	President & CEO	— mixed-class rows	390,252 mixed-class rows	$1,004,213	—	22 Feb 2022	3/4/5
SILVERBACK ASSET MANAGEMENT LLC	13F	Company	0.05%	200,000	$718,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	197,153	$708,000	—	31 Mar 2022	13F
HighTower Advisors, LLC	13F	Company	0.05%	190,388	$683,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.04%	171,800	$617,000	—	31 Mar 2022	13F
Employees Retirement System of Texas	13F	Company	0.04%	165,000	$592,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	159,261	$572,000	—	31 Mar 2022	13F
Nicolas Barthelemy	3/4/5	Director	— class O/S missing	204,077	$518,356	—	01 Apr 2022	3/4/5
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.03%	117,500	$422,000	—	31 Mar 2022	13F
Gerhard F. Burbach	3/4/5	Director	— mixed-class rows	139,398 mixed-class rows	$405,157	—	15 Jun 2022	3/4/5
Rockefeller Capital Management L.P.	13F	Company	0.03%	113,030	$405,000	—	31 Mar 2022	13F
Intellectus Partners, LLC	13F	Company	0.03%	108,368	$389,000	—	31 Mar 2022	13F
Bradley Allen Kreger	3/4/5	SVP, Global Operations	— mixed-class rows	147,741 mixed-class rows	$381,265	—	20 May 2022	3/4/5
TUDOR INVESTMENT CORP ET AL	13F	Company	0.03%	105,039	$377,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.03%	98,000	$352,000	—	31 Mar 2022	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	96,549	$347,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	96,009	$345,000	—	31 Mar 2022	13F
Nicholas Khadder	3/4/5	SVP, Gen. Counsel & Secretary	— mixed-class rows	130,021 mixed-class rows	$336,457	—	31 May 2022	3/4/5
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	93,606	$336,000	—	31 Mar 2022	13F
Bill Colston	3/4/5	Director	— mixed-class rows	101,859 mixed-class rows	$309,808	—	15 Jun 2022	3/4/5
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.02%	82,974	$297,876	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.02%	73,744	$265,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	70,300	$252,000	—	31 Mar 2022	13F
CREDIT SUISSE AG/	13F	Company	0.02%	68,384	$245,000	—	31 Mar 2022	13F
Michael F. Price	13F	Individual	0.02%	65,000	$233,000	—	31 Mar 2022	13F
ROYAL BANK OF CANADA	13F	Company	0.02%	64,916	$233,000	—	31 Mar 2022	13F
Colin McCracken	3/4/5	Chief Commercial Officer	— mixed-class rows	78,092 mixed-class rows	$201,082	—	22 Feb 2022	3/4/5
CITADEL ADVISORS LLC	13F	Company	0.01%	54,992	$197,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.01%	53,790	$193,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	52,365	$188,000	—	31 Mar 2022	13F

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2022

As of 30 Jun 2022, STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by 78 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,847,181 shares. The largest 10 holders included Indaba Capital Management, L.P., PRIMECAP MANAGEMENT CO/CA/, Neuberger Berman Group LLC, NEEDHAM INVESTMENT MANAGEMENT LLC, VANGUARD GROUP INC, MORGAN STANLEY, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., and MILLENNIUM MANAGEMENT LLC. This page lists 78 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

103

Q2 2022 holders

Holder diff

-25

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.